DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 91 filers reported holding HOMOLOGY MEDICINES INC in Q1 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.6%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q1 2020$62,740,000
-42.2%
4,037,305
-23.0%
1.99%
-42.5%
Q4 2019$108,585,000
+4.1%
5,245,638
-8.9%
3.46%
-18.5%
Q3 2019$104,263,000
-7.5%
5,760,3680.0%4.25%
+5.0%
Q2 2019$112,730,000
-22.2%
5,760,368
+10.2%
4.05%
-27.2%
Q1 2019$144,946,000
+24.0%
5,227,0350.0%5.56%
+18.8%
Q4 2018$116,877,000
-2.2%
5,227,0350.0%4.68%
+9.3%
Q3 2018$119,490,000
+12.1%
5,227,0350.0%4.28%
+14.3%
Q2 2018$106,632,000
+9.1%
5,227,0350.0%3.74%
+10.6%
Q1 2018$97,746,0005,227,0353.39%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q1 2020
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$13,789,0003.01%
Vida Ventures Advisors, LLC 770,845$2,343,0001.36%
Vivo Capital, LLC 853,143$2,594,0000.18%
OUP Management Co., LLC 64,000$195,0000.15%
TANG CAPITAL MANAGEMENT LLC 214,898$653,0000.13%
AAF Wealth Management, LLC 47,501$144,0000.10%
GSA CAPITAL PARTNERS LLP 228,365$694,0000.09%
Temasek Holdings (Private) Ltd 5,650,996$17,179,0280.07%
Bellevue Group AG 1,647,122$5,007,0000.06%
Virtus ETF Advisers LLC 35,487$108,0000.05%
View complete list of HOMOLOGY MEDICINES INC shareholders